MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by general cognitive impairment and with two distinctive pathological signs: extracellular plaques composed of amyloid β-peptide (Aβ) and intraneuronal tangles composed of hyperphosphorylated tau proteins.